Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Healthdyne Technologies

This article was originally published in The Gray Sheet

Executive Summary

Healthdyne Technologies: Board of directors unanimously rejects unsolicited acquisition offer from Invacare Corporation. Among factors influencing the decision to reject the Jan. 2 offer, valued at $190 mil., was the opinion of Healthdyne's financial advisor Cowen & Company that the offer of $12.50 per share for the 12.6 mil. outstanding shares was "grossly inadequate." In a release announcing the Jan. 24 decision, Healthdyne President and CEO Craig Reynolds states that the investment community has not fully appreciated the firm's new product entries for 1997 and 1998, and that markets "are expected to grow from approximately $575 mil. in 1996 to $1.2 bil. in 1998." Healthdyne has engaged Skadden, Arps, Slate, Meagher & Flom, LLP to act as its legal advisor...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007456

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel